{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:06:49Z","timestamp":1777417609401,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.neulet.2004.05.108","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T10:26:07Z","timestamp":1087899967000},"page":"168-170","source":"Crossref","is-referenced-by-count":25,"title":["Paraoxonase 1 (PON1) gene polymorphisms and Parkinson\u2019s disease in a Finnish population"],"prefix":"10.1016","volume":"367","author":[{"given":"Jordi","family":"Clarimon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Eerola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pentti J.","family":"Tienari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2004.05.108_BIB1","first-page":"598","article-title":"Molecular basis for the polymorphic forms of human serum paraoxonase\/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes","volume":"52","author":"Adkins","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neulet.2004.05.108_BIB2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-510X(01)00439-7","article-title":"Paraoxonase 1 Met\u2013Leu 54 polymorphism is associated with Parkinson\u2019s disease","volume":"184","author":"Akhmedova","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2004.05.108_BIB3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/taap.2002.9368","article-title":"Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians","volume":"180","author":"Allebrandt","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neulet.2004.05.108_BIB4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008571-200007000-00008","article-title":"Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype","volume":"10","author":"Brophy","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neulet.2004.05.108_BIB5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mds.10172","article-title":"Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson\u2019s disease","volume":"17","author":"Carmine","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2004.05.108_BIB6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.2001.9169","article-title":"Gene therapy to prevent organophosphate intoxication","volume":"173","author":"Cowan","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neulet.2004.05.108_BIB7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng1196-334","article-title":"The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin","volume":"14","author":"Davies","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2004.05.108_BIB8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson\u2019s disease","volume":"62","author":"de Rijk","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2004.05.108_BIB9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/toxsci\/70.1.120","article-title":"An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion","volume":"70","author":"Gentry","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neulet.2004.05.108_BIB10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2004.05.108_BIB11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2004.05.108_BIB12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jnnp.74.4.546","article-title":"Paraoxonase 1 promoter and coding region polymorphisms in Parkinson\u2019s disease","volume":"74","author":"Kelada","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2004.05.108_BIB13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(98)00586-1","article-title":"Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson\u2019s disease","volume":"806","author":"Kondo","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2004.05.108_BIB14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neulet.2004.05.108_BIB15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(99)80077-8","article-title":"Pesticides and Parkinson\u2019s disease","volume":"53","author":"Le Couteur","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neulet.2004.05.108_BIB16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","article-title":"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus","volume":"139","author":"Mackness","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neulet.2004.05.108_BIB17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.10711","article-title":"Familial aggregation of early- and late-onset Parkinson\u2019s disease","volume":"54","author":"Marder","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2004.05.108_BIB18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s004390100470","article-title":"Complex segregation analysis of Parkinson\u2019s disease in the Finnish population","volume":"108","author":"Moilanen","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neulet.2004.05.108_BIB19","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1073\/pnas.93.21.12035","article-title":"Paternal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population","volume":"93","author":"Sajantila","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2004.05.108_BIB20","unstructured":"S. Schneider, J. Kueffer, D. Roessli, L. Excoffier, Arlequin ver.2000: a software environment for the analysis of population genetics data, 2000."},{"key":"10.1016\/j.neulet.2004.05.108_BIB21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/1531-8257(200011)15:6<1265::AID-MDS1034>3.0.CO;2-0","article-title":"No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson\u2019s disease in a Chinese population","volume":"15","author":"Wang","year":"2000","journal-title":"Mov. Disord."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004007189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004007189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T14:54:43Z","timestamp":1549464883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394004007189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0304394004007189"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2004.05.108","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}